UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2023	$ 36	$ 593	$ (10,658)	$ 138,341	$ 128,313
Equity Balance, shares at Dec. 31, 2023	3,630
Common stock issued upon exercise of employee stock options, shares	8
Common stock received and retired upon exercise of stock options	$ 0	390	0	0	390
Stock option compensation expense	0	184	0	0	184
Common stock purchased and retired	$ (2)	(1,168)	0	(12,090)	(13,259)
Common stock purchased and retired, shares	(197)
Foreign currency translation adjustment	$ 0	0	769	0	769
Common stock dividends	0	0	0	(3,171)	(3,171)
Net income	0	0	0	10,972	10,972
Equity Balance, value at Sep. 30, 2024	$ 34	0	(9,890)	134,053	124,197
Equity Balance, shares at Sep. 30, 2024	3,441
Equity Balance, value at Jun. 30, 2024	$ 35	0	(11,322)	135,339	124,052
Equity Balance, shares at Jun. 30, 2024	3,499
Common stock issued upon exercise of employee stock options, shares	0
Common stock received and retired upon exercise of stock options	$ 0	0	0	0	0
Stock option compensation expense	0	53	0	0	53
Common stock purchased and retired	$ (1)	(53)	0	(3,812)	(3,866)
Common stock purchased and retired, shares	(58)
Foreign currency translation adjustment	$ 0	0	1,432	0	1,432
Common stock dividends	0	0	0	(1,038)	(1,038)
Net income	0	0	0	3,563	3,563
Equity Balance, value at Sep. 30, 2024	$ 34	0	(9,890)	134,053	124,197
Equity Balance, shares at Sep. 30, 2024	3,441
Equity Balance, value at Dec. 31, 2024	$ 33	0	(11,908)	129,302	117,427
Equity Balance, shares at Dec. 31, 2024	3,335
Stock option compensation expense	$ 0	262	0	0	262
Common stock purchased and retired	$ (1)	(262)	0	(7,098)	(7,361)
Common stock purchased and retired, shares	(131)
Foreign currency translation adjustment	$ 0	0	2,170	0	2,170
Common stock dividends	0	0	0	(2,966)	(2,966)
Net income	0	0	0	8,720	8,720
Equity Balance, value at Sep. 30, 2025	$ 32	0	(9,738)	127,958	118,252
Equity Balance, shares at Sep. 30, 2025	3,204
Equity Balance, value at Jun. 30, 2025	$ 32	0	(9,362)	126,862	117,533
Equity Balance, shares at Jun. 30, 2025	3,216
Stock option compensation expense	$ 0	95	0	0	95
Common stock purchased and retired	$ 0	(95)	0	(558)	(653)
Common stock purchased and retired, shares	(12)
Foreign currency translation adjustment	$ 0	0	(376)	0	(376)
Common stock dividends	0	0	0	(977)	(977)
Net income	0	0	0	2,631	2,631
Equity Balance, value at Sep. 30, 2025	$ 32	$ 0	$ (9,738)	$ 127,958	$ 118,252
Equity Balance, shares at Sep. 30, 2025	3,204